ANBITION

Solutions for angiogenesis, pathological angiogenesis, anti-angiogenic therapy, and synthetic peptides.

General Information
Company Name
ANBITION
Founded Year
2018
Location (Offices)
Founders / Decision Makers
Number of Employees
-
Industries
Health Care, Health and Wellness
Funding Stage
-
Social Media

ANBITION - Company Profile

ANBITION is a startup focused on providing solutions for angiogenesis, pathological angiogenesis, anti-angiogenic therapy, and synthetic peptides. Founded in 2018, the company operates in the Health Care and Health and Wellness industries. Despite a lack of specific information regarding its headquarters, ANBITION offers inquiries through phone calls and emails. As of now, there is no public record of any external investments in the company. This sector holds great potential for growth, and ANBITION's innovative approach to tackling issues within this space positions the company as an intriguing prospect for potential investors.

Taxonomy: Angiogenesis, Pathological Angiogenesis, Anti-angiogenic Therapy, Synthetic Peptides, Bioinformatics, Pharmaceuticals, Medical Research, Drug Development, Cell Signaling, Inquiry Service, Molecular Biology, Therapeutic Solutions

Funding Rounds & Investors of ANBITION (0)

View All

There is no investment information

Latest News of ANBITION

View All

No recent news or press coverage available for ANBITION.

Similar Companies to ANBITION

View All
Novelty Nobility Inc. - Similar company to ANBITION
Novelty Nobility Inc. Novel Science, Noble Management
Real Research - Similar company to ANBITION
Real Research We are determined to change the way people carry out research – moving it to the much more reliable 3D cultures
Compass Therapeutics Inc. - Similar company to ANBITION
Compass Therapeutics Inc. We are developing next-generation antibodies into transformative cancer therapies that improve patients’ lives.
Tyrogenex - Similar company to ANBITION
Tyrogenex Innovative biotech solutions for solid tumors through advanced multi-kinase angiogenesis inhibition.